FFO
IMNM icon

Fortitude Family Office’s Immunome IMNM Stock Holding History

Fortitude Family Office’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31K Hold
60
– – ﹤0.01% 1430
2025
Q4 		$1.29K Hold
60
– – ﹤0.01% 1358
2025
Q3 		$703 Hold
60
– – ﹤0.01% 1675
2025
Q2 		$558 Buy
+60
New +$492 ﹤0.01% 1748

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Fortitude Family Office's IMNM Position: Q1 2026 in Review

Fortitude Family Office held its Immunome (IMNM) position steady in Q1 2026 at 60 shares worth $1.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

Fortitude Family Office first reported a position in IMNM in Q2 2025 and has held it in 4 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Fortitude Family Office held 60 shares of Immunome worth $1.31K as of Q1 2026.
  • Fortitude Family Office left its Immunome share count unchanged in Q1 2026.
  • Immunome made up ﹤0.01% of Fortitude Family Office's portfolio in Q1 2026, its #1430 holding.
  • Fortitude Family Office first reported a position in Immunome in Q2 2025 and has held it in 4 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Fortitude Family Office's 13F filing for Q1 2026, filed 16 Apr 2026.